Clinical trial Recruiting at 2 sites Observational Ages 45 and up

Examining the link between diabetic neuropathy and muscle mass in type 2 diabetes patients

Official title: The Relation Between Diabetic Neuropathy and Muscle Mass in Type 2 Diabetes Mellitus Patients

Run by Ain Shams University · NCT06958302 · Data updated 2026-11-12

This study looks at how diabetic nerve damage affects muscle mass and strength in people over 45 with type 2 diabetes.

More Sarcopenia trials

Quick facts

Study typeObservational
Ages45 Years and up
SexAll
Enrollment60 (estimated)
SponsorAin Shams University
Academic / other
Locations2 sites (Cairo, Abbassia and 1 other locations)
StatusRecruiting
StartedMay 30, 2025
Main results expectedNovember 10, 2025
Study endsJune 15, 2026
Registry record updatedMay 6, 2025
Trial IDNCT06958302 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients diagnosed with type 2 diabetes mellitus who are aged 45 years or older.

Probably not a fit

Patients with type 1 diabetes, gestational diabetes, or those with severe comorbidities may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the relationship between diabetic neuropathy and muscle mass in patients with type 2 diabetes mellitus aged over 45. It utilizes ultrasound to measure anterior thigh muscle thickness, adjusting for body mass index to calculate muscle mass. Participants will undergo clinical tests, including hand grip strength and chair stand tests, to assess muscle power and function. The study will also investigate the prevalence of sarcopenia in this population and its correlation with diabetic neuropathy, as determined by nerve conduction studies.

Why it matters

Potential benefit: If successful, this study could enhance understanding of the interplay between muscle mass and diabetic neuropathy, potentially leading to improved management strategies for patients with type 2 diabetes.

How similar studies have gone: While there have been studies examining aspects of diabetic neuropathy and muscle mass, this specific observational approach focusing on the relationship in type 2 diabetes patients is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* The study group consisted of patients diagnosed with Type 2 diabetes mellitus aged ≥45 years old

Exclusion Criteria:

* Type 1 DM, gestational diabetes mellitus
* Severe cardiopulmonary disease, significant/previous neurological disorder (e.g., ischemic stroke, Parkinson disease) causing difficulty during daily activities (e.g., walking), visual deficit, and psychiatric problem
* Other neuropathy-associated factors such as: alcohol, nutrition, poisoning and drug addiction
* Patients with renal diseases, malignancy and autoimmune diseases
* Patients on long term use of Steroids

Where it's running

  • Ain Shams university
    Cairo, Abbassia, Egypt
    Recruiting
  • Ain Shams university
    Cairo, Abbassia, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.